Brief: GoodRx Holdings Q3 Adjusted Net Income USD 31.9 Million Vs. IBES Estimate USD 33 Million
07/11/2024 11:05
Nov 07 (Reuters) - GoodRx Holdings Q3 adjusted EBITDA USD 65 million vs. IBES estimate USD 62.6 million. * Q3 net income USD 4 million * Q3 adjusted EBITDA margin 33.3% * Q3 revenue USD 195.3 million vs. IBES estimate USD 195.7 million
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million